Literature DB >> 28413537

Progressive hemiparesis in a young man: Hemicerebral atrophy as the initial manifestation of basal ganglia germinoma.

Peter Yat Ming Woo1, Alberto Chi Ho Chu1, Kwong Yau Chan1, John Ching Kwong Kwok1.   

Abstract

Basal ganglia germinomas are rare and patients are classically young Oriental males presenting with gradually progressive hemiparesis. Although early treatment with chemo-radiotherapy can be curative and significantly improve the quality of life, medical attention is often delayed. A young Chinese male experienced a 6-month history of right hemiparesis with magnetic resonance imaging findings of hemicerebral atrophy and lentiform nucleus microhemorrhage, highly suggestive and early signs of basal ganglia germinomas. No further imaging was performed until 2 years later when he was admitted for acute neurological deterioration and a repeat scan revealed a large infiltrative tumor pathologically confirmed to be a pure germinoma.

Entities:  

Keywords:  Basal ganglia germinoma; Wallerian degeneration; cerebral hemi-atrophy; gradient echo imaging; hemicerebral atrophy

Year:  2017        PMID: 28413537      PMCID: PMC5379809          DOI: 10.4103/1793-5482.145083

Source DB:  PubMed          Journal:  Asian J Neurosurg


Introduction

Primary basal ganglia germinomas are rare with fewer than a hundred cases reported.[1] Although difficult to diagnose in the early stages of disease radiotherapy can be curative.[2] Typical radiological features of advanced disease are well-described, but magnetic resonance imaging (MRI) revealing the presence of hemicerebral atrophy, a reliable early sign, is seldom reported.[23456789] We describe a patient where interval disease progression was seen 2 years after presenting with non-specific progressive hemiparesis. The initial finding of hemicerebral atrophy and subtle left globus pallidus signal changes on diffusion-weighted imaging (DWI) and gradient-echo (GRE) imaging were the first diagnostic clues of an underlying basal ganglia germinoma.

Case Report

A 21-year-old healthy ethnic Chinese male experienced gradual onset of progressive right hemiparesis for 6 months. There were no symptoms to suggest raised intracranial pressure. On examination, the patient had mild right hemiparesis, but was able to walk unaided. There was no other focal neurological deficit; in particular there were no extra-pyramidal signs. Non-contrast enhanced MRI brain scans depicted left hemicerebral atrophy involving the basal ganglia, cerebral peduncle, midbrain as well as the left cerebral cortex. There were also subtle T2-weighted hyperintense signals at the left globus pallidus and the posterior limb of the left internal capsule [Figure 1a and b]. On DWI, there was evidence of restricted diffusion over the same region associated with susceptibility changes on GRE sequences suggesting a possible left basal ganglia tumor with previous microhemorrhage [Figure 1c and d]. Neither contrast-enhanced imaging, magnetic resonance spectroscopy nor other forms of susceptibility-weighted imaging (SWI) were performed. A private clinician assessed the patient at the time and despite the abnormal radiological findings no further investigations were arranged. After 2 years, he experienced acute symptoms of raised intracranial pressure associated with right hemiplegia. Repeat imaging revealed a large cystic lesion arising from the left globus pallidus [Figure 1e–g]. Serum concentrations for alpha-fetoprotein (AFP) and beta-human chorionic gonadotrophin (HCG) were both normal. Craniotomy with near total excision was performed and histology revealed large pleomorphic cells with prominent nucleoli and reactive lymphocytic infiltrates [Figure 2a]. Immunohistochemistry identified the tumor cells to be positive for placental alkaline phosphatase (PLAP) and strongly reactive to membranous c-kit (CD117), a distinctive feature of pure germinomas [Figure 2b and c]. A combined whole-body positron-emission tomography (PET) and computed tomography (CT) scan showed no other lesion. The patient received cranio-spinal radiotherapy and six courses of systemic vincristine, bleomycin, cisplatin and etoposide adjuvant chemotherapy. Post-operatively he experienced significant neurological recovery and could walk unaided upon discharge. At 6-month post-treatment, MRI scans showed complete disease remission [Figure 1h].
Figure 1

Initial T1W magnetic resonance imaging (MRI): Left hemicerebral atrophy with diffuse sulcal widening and prominent left sylvian fissure without ventricular enlargement (a); T2W: Subtle hyperintense signal changes at the left globus pallidus and posterior limb of the internal capsule (b); DWI: Restricted diffusion of the same areas (white arrow, c) and GRE: Hypointense signals (“blooming”) (black arrow, d); 2 years later: Large left basal ganglia cystic lesion (T2W with left cerebral peduncle atrophy, white thin arrow (e); T2W (f); contrast T1W (g); 6-month post-treatment contrast T1W MRI showed no recurrent tumor (h)

Figure 2

Photo-micrograph. H and E stain. Sheets of large pleomorphic tumor cells with enlarged nuclei, prominent nucleoli and vacuolated cytoplasm. Note hemosiderin deposition in the center (arrow head, a); Placental alkaline phosphatase reactive staining (b); and strong diffuse c-kit positivity characteristic of pure germinomas (c)

Initial T1W magnetic resonance imaging (MRI): Left hemicerebral atrophy with diffuse sulcal widening and prominent left sylvian fissure without ventricular enlargement (a); T2W: Subtle hyperintense signal changes at the left globus pallidus and posterior limb of the internal capsule (b); DWI: Restricted diffusion of the same areas (white arrow, c) and GRE: Hypointense signals (“blooming”) (black arrow, d); 2 years later: Large left basal ganglia cystic lesion (T2W with left cerebral peduncle atrophy, white thin arrow (e); T2W (f); contrast T1W (g); 6-month post-treatment contrast T1W MRI showed no recurrent tumor (h) Photo-micrograph. H and E stain. Sheets of large pleomorphic tumor cells with enlarged nuclei, prominent nucleoli and vacuolated cytoplasm. Note hemosiderin deposition in the center (arrow head, a); Placental alkaline phosphatase reactive staining (b); and strong diffuse c-kit positivity characteristic of pure germinomas (c)

Discussion

Primary intracranial pure germinomas tumors are uncommon representing 3% of all intracranial tumors in children and adolescents.[310] There is a higher reported prevalence among Oriental males with a peak incidence during the second decade of life.[31011] They are believed to arise from midline totipotent cell nests arrested during their migration in rostral neural tube development. For this reason, most originate from midline structures such as the suprasellar and pineal regions. Five to ten per cent of germinomas arise off-midline from the basal ganglia and are considered to be rare and “ectopic.” Most originate from the lentiform nucleus and are presumed to be a result of aberrant migration of ectopic germ cells during third ventricle development.[412] From a single-center series in Hong Kong, China, of 432 pediatric brain tumor patients with pathological diagnoses, Wong et al. reported that 6 of 13 patients with basal ganglia tumors were primary germinomas.[1] They concluded that germinomas are the most common basal ganglia tumors in children. The onset of primary basal ganglia germinomas is insidious, usually in terms of years and in a single case, the diagnosis was made after 8 years.[31013] Patients present with subtle, but progressive pyramidal signs due to the tumor's proximity to the posterior limb of the internal capsule.[1] Slow infiltration of the basal ganglia and thalamus could lead to extra-pyramidal signs such as choreo-athetosis.[3] Other common symptoms include neuropsychiatric manifestations such as gradual cognitive deterioration, personality changes and psychosis when the deep limbic structures are involved.[3] Early disease basal ganglia germinomas are elusive on imaging. CT scans may appear normal unless features of advanced disease such as intratumoral hemorrhage, calcifications or cystic degeneration are present.[4514] In this case, the tumor developed into a multi-loculated complex cyst, a characteristic finding of basal ganglia geminomas, unlike their pineal or suprasellar region counterparts where solid lesions predominate.[2] The MRI features of basal ganglia germinomas are generally non-specific: Iso-or hypo-intense on T1-weighted images and iso-or hyper-intense on T2-weighted sequences. Contrast enhancement only occurs in established disease. As illustrated in this case basal ganglia germinomas are thought to arise from small lenticular lesions and hemiparesis may even precede a demonstrable tumor. Thus, recognition of hemicerebral atrophy becomes highly important in identifying early disease. In a series of 17 patients, one-third had hemicerebral atrophy observed on MRI.[215] Although, this phenomenon has long been known to be associated with basal ganglia germinomas surprisingly few cases have been reported.[13489151617] It is postulated that germinoma cells cause degeneration of ganglion cells and nerve fibers within its vicinity. Subsequent infiltration of the corticospinal and thalamo-cortical tracts elicits secondary antegrade and retrograde Wallerian degeneration of the ipsilateral cerebral hemisphere extending from the corona radiata to the internal capsule and brainstem.[1616] DWI showing restricted diffusion suggests the presence of a hypercellular tumor, but this is non-specific and is a shared characteristic of lymphomas.[346] Owing to the propensity for germinomas to develop an extensive vasculature micro-hemorrhages detectable on GRE and SWI may be useful. Both sequences accentuate the paramagnetic properties of blood products such as deoxyhemoglobin, intracellular methemoglobin and hemosiderin. In addition, germinoma GRE- and SWI-signal changes may be explained by two other mechanisms. Since the basal ganglia are especially rich in iron content tumor invasion could cause a disruption of its axonal transport and lead to abnormal iron accumulation within the lesion's vicinity.[7] Another hypothesis involves the possible germinoma paracrine secretion of transferrin that activates glial cell receptors to promote the transport of iron to the globus pallidus.[7] Apparently, this patient's initial subtle left pallidal DWI and GRE signal changes should have alerted the responsible clinician to arrange for an interval MRI. Metabolic imaging shows promise of early detection in cases where MRI features are ambiguous. Fluorine 18-flurodeoxyglucose PET shows characteristic hypometabolism that is particularly useful in differentiating from high grade gliomas and lymphomas.[18] Several studies have reported that C11-methionine-PET is highly sensitive for basal ganglia germinomas especially for recurrent disease.[918] Immunohistochemical diagnostic biomarkers such as PLAP, AFP, HCG, c-kit/CD117 and OCT4, aid in the identification of a variety of germ cell tumors. In particular PLAP reactivity is characteristic of pure germinomas in more than 90% of cases and almost all demonstrate strong c-kit/CD117 positivity.[10] OCT4 is not only diagnostically useful, with reactivity close to 100% of germinomas, but the variance in expression carries prognostic significance with regard to 5-year progression-free survival.[19] For this patient, there was no HCG staining reactivity, a distinctive feature for germinomas with syncytiotrophoblastic elements that carry a worse prognosis. It has been proposed that a greater proportion of intracranial germinomas stain positive for vimentin and epithelial membrane antigen compared with their gonadal counterparts, but this has yet to be substantiated with larger studies and the role of these markers are typically limited to the identification of meningiomas or sarcomas.[2021] Lymphocytic infiltration with granulomatous inflammation may confound the diagnosis and suggest sarcoidosis or infection. Familiarity with the clinical and imaging features often clarifies suspicions. Other possible differential diagnoses include non-Hodgkin's lymphomas that are readily identified with leukocyte common antigen (CD 45) positive staining. Large germinomas as in this case can trigger a gliotic reaction and mimic gliomas particularly if biopsies are taken from the periphery. Glial fibrillary acidic protein positive and PLAP negative stains promptly identifies glial tumors. The first line treatment of primary intracranial germinomas is cranio-spinal radiotherapy and more than 90% of patients can achieve 5-year overall survival.[10] Chemotherapy is often added to reduce radiotherapy dosages and mitigate radiation toxicity, but it is unclear whether chemotherapy alone improves survival.[1017] Surgery is reserved for lesions presenting with mass effect or when they radiologically mimic high grade gliomas or lymphomas.[17]

Conclusion

Early stage intracranial primary basal ganglia germinomas should be considered when MRI findings reveal hemicerebral atrophy or ill-defined lentiform nucleus lesions in young Oriental males with progressive hemiparesis. Recognition of this phenomenon will prevent delayed treatment and irreversible neurological deficit in a tumor with an otherwise favorable prognosis.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.
  21 in total

1.  Immunohistochemical differences between intracranial germinomas and their gonadal equivalents. An immunoperoxidase study of germ cell tumors with epithelial membrane antigen, cytokeratin, and vimentin.

Authors:  Y Nakagawa; E Perentes; G W Ross; A N Ross; L J Rubinstein
Journal:  J Pathol       Date:  1988-09       Impact factor: 7.996

2.  Germinoma: unusual imaging and pathological characteristics. Report of two cases.

Authors:  Elisabeth J Rushing; Glenn D Sandberg; Alexander R Judkins; Gilbert Vezina; Nadja Kadom; John S Myseros; Roger J Packer; Mariarita Santi
Journal:  J Neurosurg       Date:  2006-02       Impact factor: 5.115

Review 3.  Germ cell tumor arising in the basal ganglia in a female--case report.

Authors:  H Kobayashi; H Yamada; N Sakai; T Andoh; J Shinoda
Journal:  Neurol Med Chir (Tokyo)       Date:  1990-02       Impact factor: 1.742

Review 4.  Germinoma of the basal ganglia. An 8-year asymptomatic history after detection of abnormality on CT.

Authors:  Naoya Takeda; Katsuzo Fujita; Shigenori Katayama; Yoshito Uchihashi; Yusuke Okamura; Hiroyuki Nigami; Kimio Hashimoto; Eiji Kohmura
Journal:  Pediatr Neurosurg       Date:  2004 Nov-Dec       Impact factor: 1.162

5.  Germinomas in the basal ganglia: magnetic resonance imaging classification and the prognosis.

Authors:  Ji Hoon Phi; Byung-Kyu Cho; Seung-Ki Kim; Jin Chul Paeng; In-One Kim; Il Han Kim; Dong Gyu Kim; Hee-Won Jung; Jeong Eun Kim; Kyu-Chang Wang
Journal:  J Neurooncol       Date:  2010-01-20       Impact factor: 4.130

6.  Inherent diagnostic and treatment challenges in germinoma of the basal ganglia: a case report and review of the literature.

Authors:  Anita Villani; Eric Bouffet; Susan Blaser; Barbara-Ann Millar; Cynthia Hawkins; Ute Bartels
Journal:  J Neurooncol       Date:  2008-03-26       Impact factor: 4.130

7.  Basal ganglia germinoma in children with associated ipsilateral cerebral and brain stem hemiatrophy.

Authors:  Rodrigo V Ozelame; Manohar Shroff; Bradley Wood; Eric Bouffet; Ute Bartels; James M Drake; Cynthia Hawkins; Susan Blaser
Journal:  Pediatr Radiol       Date:  2006-02-04

8.  MRI of germinomas arising from the basal ganglia and thalamus.

Authors:  D I Kim; P H Yoon; Y H Ryu; P Jeon; G J Hwang
Journal:  Neuroradiology       Date:  1998-08       Impact factor: 2.804

9.  Susceptibility-weighted imaging in the diagnosis of early basal ganglia germinoma.

Authors:  X Lou; L Ma; F-L Wang; Z-P Tang; H Huang; Y-Q Cai; E-H-C Wong
Journal:  AJNR Am J Neuroradiol       Date:  2009-07-06       Impact factor: 3.825

10.  Primary intracranial germ cell tumors.

Authors:  Shagufta Tahir Mufti; Awatif Jamal
Journal:  Asian J Neurosurg       Date:  2012-10
View more
  2 in total

1.  T2*-based MR imaging (gradient echo or susceptibility-weighted imaging) in midline and off-midline intracranial germ cell tumors: a pilot study.

Authors:  Giovanni Morana; Cesar Augusto Alves; Domenico Tortora; Jonathan L Finlay; Mariasavina Severino; Paolo Nozza; Marcello Ravegnani; Marco Pavanello; Claudia Milanaccio; Mohamad Maghnie; Andrea Rossi; Maria Luisa Garrè
Journal:  Neuroradiology       Date:  2017-11-11       Impact factor: 2.804

2.  [Clinical analysis of 30 cases of basal ganglia germinoma in children].

Authors:  S L Wang; Y X Gao; H W Zhang; H B Yang; H Li; Y Li; L X Shen; H X Yao
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2022-04-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.